About E3 ubiquitin-protein ligase RNF13
E3 ubiquitin-protein ligase RNF13 (RNF13) is a protein
from Homo sapiens identified by UniProt accession
O43567, 381 residues long.
MolForge cross-references it against 0 known binders and
65 disease associations.
Target properties
| Protein name | E3 ubiquitin-protein ligase RNF13 |
| UniProt accession | O43567 |
| Gene | RNF13 |
| Organism | Homo sapiens |
| Length | 381 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (65)
Diseases linked to this target (Open Targets).
- developmental and epileptic encephalopathy · score 0.48
- smoking status measurement · score 0.26
- myocardial infarction · score 0.23
- attention deficit hyperactivity disorder · score 0.23
- antisocial behaviour measurement · score 0.23
- substance abuse · score 0.23
- diet measurement · score 0.22
- pulse pressure measurement · score 0.20
- neoplasm · score 0.08
- hepatocellular carcinoma · score 0.08
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O43567-F1 | alphafold | PREDICTED | 74.44 | — |
Amino-acid sequence (381 residues)
MLLSIGMLML SATQVYTILT VQLFAFLNLL PVEADILAYN FENASQTFDD LPARFGYRLP AEGLKGFLIN SKPENACEPI VPPPVKDNSS GTFIVLIRRL DCNFDIKVLN AQRAGYKAAI VHNVDSDDLI SMGSNDIEVL KKIDIPSVFI GESSANSLKD EFTYEKGGHL ILVPEFSLPL EYYLIPFLII VGICLILIVI FMITKFVQDR HRARRNRLRK DQLKKLPVHK FKKGDEYDVC AICLDEYEDG DKLRILPCSH AYHCKCVDPW LTKTKKTCPV CKQKVVPSQG DSDSDTDSSQ EENEVTEHTP LLRPLASVSA QSFGALSESR SHQNMTESSD YEEDDNEDTD SSDAENEINE HDVVVQLQPN GERDYNIANT V
Explore E3 ubiquitin-protein ligase RNF13 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets